Results 161 to 170 of about 206,766 (202)
Some of the next articles are maybe not open access.
Safety and efficacy of vaccines
Dermatologic Therapy, 2009For the past two centuries, vaccines have provided a safe and effective means of preventing a number of infectious diseases. Although the safety of some vaccines has been questioned in recent years, the currently available vaccines are more than a millionfold safer than the diseases they are designed to prevent. Vaccines, however, should always be used
Brenda L, Bartlett, Stephen K, Tyring
openaire +2 more sources
Primary Care: Clinics in Office Practice, 2001
The end of the 20th century saw the realization of a goal that was previously only dreamed about: the near elimination of many deadly infectious diseases through universal vaccination. As one disease after another has been driven from memory, it is vaccination programs themselves that have come to occupy the public's mind. With increased scrutiny comes
G S, Marshall, B G, Gellin
openaire +2 more sources
The end of the 20th century saw the realization of a goal that was previously only dreamed about: the near elimination of many deadly infectious diseases through universal vaccination. As one disease after another has been driven from memory, it is vaccination programs themselves that have come to occupy the public's mind. With increased scrutiny comes
G S, Marshall, B G, Gellin
openaire +2 more sources
Immunology and Allergy Clinics of North America, 2003
Rates of reported adverse events are remarkably low. VAERS identifies an adverse event rate approximating 11.4 reports per 100,000 vaccine doses. Approximately 15% of these reports represent SAEs, but less than 2% involve death; in most cases, reviews have shown no causal relation between the events and the vaccine.
openaire +2 more sources
Rates of reported adverse events are remarkably low. VAERS identifies an adverse event rate approximating 11.4 reports per 100,000 vaccine doses. Approximately 15% of these reports represent SAEs, but less than 2% involve death; in most cases, reviews have shown no causal relation between the events and the vaccine.
openaire +2 more sources
International Journal of Risk & Safety in Medicine, 2011
Brief reports are presented on Swissmedic's experiences with PaniFlow™, a tool to monitor Adverse Events Following Immunization (AEFI) of pandemic influenza (H1N1) 2009 vaccines and UMC's updates on AEFI of these vaccines; on WHO's Global Network for Post-marketing Surveillance of Prequalified Vaccines and India joining the network; the June 2010 ...
openaire +2 more sources
Brief reports are presented on Swissmedic's experiences with PaniFlow™, a tool to monitor Adverse Events Following Immunization (AEFI) of pandemic influenza (H1N1) 2009 vaccines and UMC's updates on AEFI of these vaccines; on WHO's Global Network for Post-marketing Surveillance of Prequalified Vaccines and India joining the network; the June 2010 ...
openaire +2 more sources
The challenge of vaccine safety
Seminars in Pediatric Infectious Diseases, 2002Vaccines always will involve some risk, and risk always involves some public concern. Although the benefits of routine vaccination greatly outweigh any adverse effects, our consumer society seeks to eliminate all risk. The balance of risk and benefit appears to falter by the very success of preventing disease: in the immediate absence of the disease ...
Robert M, Jacobson +2 more
openaire +2 more sources
Current Opinion in Allergy & Clinical Immunology, 2012
To review recent publications on the safety of influenza vaccines [both the injectable, inactivated trivalent influenza vaccine (TIV) and the intranasal, live attenuated influenza vaccine (LAIV)] and new recommendations regarding their use.Numerous studies have demonstrated that TIV can be safely administered to patients with egg allergy.
openaire +2 more sources
To review recent publications on the safety of influenza vaccines [both the injectable, inactivated trivalent influenza vaccine (TIV) and the intranasal, live attenuated influenza vaccine (LAIV)] and new recommendations regarding their use.Numerous studies have demonstrated that TIV can be safely administered to patients with egg allergy.
openaire +2 more sources
Vaccine Safety Controversies and the Future of Vaccination Programs
The Pediatric Infectious Disease Journal, 2005In the years following the hepatitis B vaccination/multiple sclerosis controversy, a number of new issues regarding vaccine safety have been raised, in some cases leading to more debate and confusion. Against this background, an international group of experts was convened to review the current points of view concerning the use of thimerosal as a ...
François, Guido +9 more
openaire +3 more sources